The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.
The industry needs to embrace innovation with technology towards novel drug development to remain relevant in the marketplace.
Latin America is the latest battlefield for the billions in the global showdown between smaller generic labels from the developing world and the major U.S. and European firms.